Consumer Health Diabetes
Novo Nordisk Secures US FDA Approval For Once Daily Oral GLP 1 Weight Management Pill
The US Food and Drug Administration (FDA) has approved Novo Nordisk's new once-daily pill for weight management, designed to help people reduce excess body...
January 29, 2026 | News
BioMed X Launches EU Backed AI Precision Medicine Project With Barbados To Address Early Diabetic Kidney Disease
The new project, supported by the European Union’s PharmaNext Programme, focuses on population-specific molecular profiling and AI-driven precision m...
January 28, 2026 | News
Ascletis Pharma Inc. Advances ASC30 Into U.S. Phase II Diabetes Study With Topline Data Expected In Q3 2026
-Topline data from the Phase II study for the treatment of diabetes are expected in the third quarter of 2026. -ASC30&n...
January 27, 2026 | News
C&R Research Deepens Indonesia Engagement Through Global Clinical Trial Capabilities
Accelerating Indonesia Collaboration through Global Clinical Capabilities C&R Research, founded in 1997 as Korea's first full-service Contract R...
January 06, 2026 | News
Ascletis Secures US FDA IND Clearance For Phase II Diabetes Study Of Oral GLP One Candidate ASC30
-The Phase II study for diabetes is a 13-week, randomized, double-blind, placebo-controlled and multi-center study to evaluate the effi...
January 06, 2026 | News
CivicaScript Expands Affordable Biosimilar Access With Insulin And Ustekinumab Launches
CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines and biosimilars to U.S. patients, announced the availabi...
January 06, 2026 | News
Medtronic Files For MiniMed IPO As Diabetes Business Prepares For Public Market Separation
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced that its Diabetes business, which as previously announced will operate under...
December 29, 2025 | News
MEDI&GENE Enters Catalyze Agreement With Eli Lilly To Advance Next Generation Obesity Therapy
MEDI&GENE, a biopharmaceutical company developing therapeutics for metabolic diseases, announced today that it has entered into a Catalyze agreeme...
December 19, 2025 | News
Avant Technologies and SGAustria Form Joint Venture to Pioneer Stem Cell–Based Diabetes Therapies
Avant Technologies Inc. (OTCQB: AVAI) (“Avant” or the “Company”), a Nevada-based corporation, and SGAustria Pte. Ltd. (SGAustria), ...
November 06, 2025 | News
Phenomix’s MyPhenome Test Validates GLP-1 Response Prediction Across 88,000 Patients
Studies presented at Obesity Week 2025 validate the test's ability to predict weight-loss response to GLP-1 drugs like semaglutide, including in ...
November 05, 2025 | Report
Novo Nordisk Launches Wegovy® in Hong Kong to Tackle Rising Obesity Rates with Proven Long-Term Weight Management Therapy
Wegovy® (semaglutide) is a once-weekly injectable prescription medicine used in combination with a reduced calorie diet and increased physical a...
November 04, 2025 | News
Sandstone Medical Expands Easydrip™ Plus Pen Needle Portfolio to Turkey
Sandstone Medical — a SteriLance Medical sub‑brand focused on diabetes self‑injection — announced the introduction of its Easydr...
October 13, 2025 | News
COREE Identifies First-Ever Microbiome Biomarkers for Diabetes and Obesity Patients
COREE announced on September 15 that it had, for the first time in the world, identified microbiome biomarkers specific to diabetes and obesity p...
September 29, 2025 | News
The $100 Billion Question: Can India Lead the Global Diabetes Economy?
India’s Diabetes Burden and Global Stakes: India is often called the “diabetes capital of the world,” and not without reason. Recent esti...
September 24, 2025 | Analysis | By editor@biopharmaapac.com
Most Read
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
